These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 884924)

  • 21. Comparative metabolism and excretion of adriamycin in man, monkey, and rat.
    Wilkinson PM; Israel M; Pegg WJ; Frei E
    Cancer Chemother Pharmacol; 1979; 2(2):121-5. PubMed ID: 119583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Pierce RN; Jatlow PI
    J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.
    Eksborg S; Ehrsson H; Andersson I
    J Chromatogr; 1979 Dec; 164(4):479-86. PubMed ID: 541423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adriamycin metabolism in man. Evidence from urinary metabolites.
    Takanashi S; Bachur NR
    Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.
    Eksborg S; Cedermark BJ; Strandler HS
    Med Oncol Tumor Pharmacother; 1985; 2(1):47-54. PubMed ID: 4058077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
    Eksborg S; Stendahl U; Lönroth U
    Eur J Clin Pharmacol; 1986; 30(5):629-31. PubMed ID: 3463510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of 4'-epi-doxorubicin in man.
    Weenen H; Lankelma J; Penders PG; McVie JG; ten Bokkel Huinink WW; de Planque MM; Pinedo HM
    Invest New Drugs; 1983; 1(1):59-64. PubMed ID: 6590528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration.
    Lee YT; Chan KK; Harris PA; Cohen JL
    Cancer; 1980 May; 45(9):2231-9. PubMed ID: 7379023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
    Cummings J; Stuart JF; Calman KC
    J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
    Cummings J; Merry S; Willmott N
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner.
    Watson E; Chan KK
    Cancer Treat Rep; 1976 Nov; 60(11):1611-8. PubMed ID: 1035506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in adriamycin efficacy by phenobarbital.
    Reich SD; Bachur NR
    Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and tissue distribution changes of adriamycin and adriamycinol after intravenous administration of adriamycin to uranyl nitrate-induced acute renal failure rats.
    Lee HJ; Paik WH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):195-204. PubMed ID: 8832911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites.
    Preiss R; Sohr R; Kittelmann B; Müller E; Haase D
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):156-64. PubMed ID: 2714916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.